Literature DB >> 18081910

The reliability of the MSFC and its components.

E Rosti-Otajärvi1, P Hämäläinen, K Koivisto, L Hokkanen.   

Abstract

BACKGROUND: The Multiple Sclerosis Functional Composite (MSFC) is a multidimensional measurement tool for multiple sclerosis (MS) including a measure of ambulation (Timed 25-foot Walk [TWT]), arm function (Nine-Hole Peg Test [9HPT]) and cognition (Paced Auditory Serial Addition Test [PASAT]).
OBJECTIVES: To assess the reliability and practice effects in the Finnish version of the MSFC and its components.
MATERIALS AND METHODS: Ten relapsing-remitting MS patients and 10 healthy controls underwent five testing sessions with the MSFC over a 4-week period.
RESULTS: The MSFC showed excellent intra- (0.99) and inter-rater (1.0) reliability. The MSFC, especially the 9HPT and the PASAT showed significant practice effects. On the 9HPT the controls remained stable whereas the patients improved their performance; on the PASAT both groups improved.
CONCLUSIONS: The MSFC showed excellent intra- and inter-rater reliability although the 9HPT and the PASAT were prone to considerable practice effects.

Entities:  

Mesh:

Year:  2007        PMID: 18081910     DOI: 10.1111/j.1600-0404.2007.00972.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  18 in total

1.  Longitudinal relationships among posturography and gait measures in multiple sclerosis.

Authors:  Nora E Fritz; Scott D Newsome; Ani Eloyan; Rhul Evans R Marasigan; Peter A Calabresi; Kathleen M Zackowski
Journal:  Neurology       Date:  2015-04-15       Impact factor: 9.910

2.  Distinguishing among multiple sclerosis fallers, near-fallers and non-fallers.

Authors:  Nora E Fritz; Ani Eloyan; Moira Baynes; Scott D Newsome; Peter A Calabresi; Kathleen M Zackowski
Journal:  Mult Scler Relat Disord       Date:  2017-11-22       Impact factor: 4.339

3.  Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.

Authors:  Suzanne L Barker-Collo; Suzanne C Purdy
Journal:  Int J MS Care       Date:  2013

4.  How does performance of the Friedreich Ataxia Functional Composite compare to rating scales?

Authors:  Geneieve Tai; Eppie M Yiu; Martin B Delatycki; Louise A Corben
Journal:  J Neurol       Date:  2017-07-10       Impact factor: 4.849

Review 5.  Upper Extremity Capability Tests in Multiple Sclerosis.

Authors:  R Gökçen Gözübatık Çelik
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

6.  The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.

Authors:  Peter Feys; Ilse Lamers; Gordon Francis; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn D Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

7.  Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.

Authors:  Robert W Motl; Jeffrey A Cohen; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn D Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

8.  Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties.

Authors:  Kamila Rasova; Patricia Martinkova; Jana Vyskotova; Michaela Sedova
Journal:  Patient Relat Outcome Meas       Date:  2012-10-11

Review 9.  Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.

Authors:  Sandra Meyer-Moock; You-Shan Feng; Mathias Maeurer; Franz-Werner Dippel; Thomas Kohlmann
Journal:  BMC Neurol       Date:  2014-03-25       Impact factor: 2.474

10.  Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.

Authors:  Janina Behrens; Caspar Pfüller; Sebastian Mansow-Model; Karen Otte; Friedemann Paul; Alexander U Brandt
Journal:  J Neuroeng Rehabil       Date:  2014-05-27       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.